The European Medicines Agency review of vemurafenib (Zelboraf®) for the treatment of adult patients with BRAF V600 mutation-positive unresectable or metastatic melanoma: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use

Medicinal Products ◽

Scientific Assessment ◽

Human Use ◽

Braf V600 Mutation

The European Medicines Agency review of ipilimumab (Yervoy) for the treatment of advanced (unresectable or metastatic) melanoma in adults who have received prior therapy: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use

European Journal of Cancer ◽

10.1016/j.ejca.2011.09.018 ◽

2012 ◽

Vol 48 (2) ◽

pp. 237-242 ◽

Cited By ~ 39

Author(s):

Zahra Hanaizi ◽

Barbara van Zwieten-Boot ◽

Gonzalo Calvo ◽

Arantxa Sancho Lopez ◽

Maaike van Dartel ◽

...

Keyword(s):

Metastatic Melanoma ◽

Medicinal Products ◽

Prior Therapy ◽

Scientific Assessment ◽

The European Medicines Agency Review of Decitabine (Dacogen) for the Treatment of Adult Patients With Acute Myeloid Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

The Oncologist ◽

10.1634/theoncologist.2015-0298 ◽

2016 ◽

Vol 21 (6) ◽

pp. 692-700 ◽

Cited By ~ 24

Author(s):

Maria Nieto ◽

Pierre Demolis ◽

Eliane Béhanzin ◽

Alexandre Moreau ◽

Ian Hudson ◽

...

Keyword(s):

Acute Myeloid Leukemia ◽

Myeloid Leukemia ◽

Adult Patients ◽

Medicinal Products ◽

Scientific Assessment ◽

Human Use ◽

Acute Myeloid

The European Medicines Agency Review of Pomalidomide in Combination With Low‐Dose Dexamethasone for the Treatment of Adult Patients With Multiple Myeloma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

The Oncologist ◽

10.1634/theoncologist.2014-0073 ◽

2015 ◽

Vol 20 (3) ◽

pp. 329-334 ◽

Cited By ~ 13

Author(s):

Zahra Hanaizi ◽

Beatriz Flores ◽

Robert Hemmings ◽

Jorge Camarero ◽

Arantxa Sancho‐Lopez ◽

...

Keyword(s):

Multiple Myeloma ◽

Low Dose ◽

Adult Patients ◽

Medicinal Products ◽

Scientific Assessment ◽

The European Medicines Agency Review of Bosutinib for the Treatment of Adult Patients With Chronic Myelogenous Leukemia: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

The Oncologist ◽

10.1634/theoncologist.2013-0294 ◽

2014 ◽

Vol 19 (4) ◽

pp. 421-425 ◽

Cited By ~ 5

Author(s):

Zahra Hanaizi ◽

Christoph Unkrig ◽

Harald Enzmann ◽

Jorge Camarero ◽

Arantxa Sancho‐Lopez ◽

...

Keyword(s):

Chronic Myelogenous Leukemia ◽

Adult Patients ◽

Myelogenous Leukemia ◽

Medicinal Products ◽

Scientific Assessment ◽

The European Medicines Agency Review of Pertuzumab for the Treatment of Adult Patients With HER2‐Positive Metastatic or Locally Recurrent Unresectable Breast Cancer: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

The Oncologist ◽

10.1634/theoncologist.2013-0348 ◽

2014 ◽

Vol 19 (7) ◽

pp. 766-773 ◽

Cited By ~ 15

Author(s):

Hector Boix‐Perales ◽

Jeanett Borregaard ◽

Kristina Bech Jensen ◽

Jens Ersbøll ◽

Sara Galluzzo ◽

...

Keyword(s):

Breast Cancer ◽

Adult Patients ◽

Medicinal Products ◽

Her2 Positive ◽

Scientific Assessment ◽

Locally Recurrent ◽

The European Medicines Agency Review of Pixantrone for the Treatment of Adult Patients With Multiply Relapsed or Refractory Aggressive Non‐Hodgkin's B‐Cell Lymphomas: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

The Oncologist ◽

10.1634/theoncologist.2013-0020 ◽

2013 ◽

Vol 18 (5) ◽

pp. 625-633 ◽

Cited By ~ 23

Author(s):

Elias Péan ◽

Beatriz Flores ◽

Ian Hudson ◽

Jan Sjöberg ◽

Kristina Dunder ◽

...

Keyword(s):

B Cell ◽

Adult Patients ◽

Medicinal Products ◽

B Cell Lymphomas ◽

Scientific Assessment ◽

The European Medicines Agency Review of Pazopanib for the Treatment of Advanced Renal Cell Carcinoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-11-1734 ◽

2011 ◽

Vol 17 (21) ◽

pp. 6608-6614 ◽

Cited By ~ 18

Author(s):

Maria Nieto ◽

Jeanett Borregaard ◽

Jens Ersbøll ◽

George J.A. ten Bosch ◽

Barbara van Zwieten-Boot ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Renal Cell ◽

Advanced Renal Cell Carcinoma ◽

Medicinal Products ◽

Scientific Assessment ◽

The European Medicines Agency approval of 5-aminolaevulinic acid (Ameluz) for the treatment of actinic keratosis of mild to moderate intensity on the face and scalp: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use

Journal of Dermatological Treatment ◽

10.3109/09546634.2013.789474 ◽

2013 ◽

Vol 25 (5) ◽

pp. 371-374 ◽

Cited By ~ 3

Author(s):

Kyriaki Tzogani ◽

Myrjam Straube ◽

Ute Hoppe ◽

Peter Kiely ◽

Geraldine O’Dea ◽

...

Keyword(s):

Actinic Keratosis ◽

Moderate Intensity ◽

Medicinal Products ◽

Scientific Assessment ◽

Aminolaevulinic Acid ◽

The Face ◽

The European Medicines Agency Review of Eribulin for the Treatment of Patients with Locally Advanced or Metastatic Breast Cancer: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-11-3075 ◽

2012 ◽

Vol 18 (17) ◽

pp. 4491-4497 ◽

Cited By ~ 29

Author(s):

Elias Pean ◽

Sigrid Klaar ◽

Eva Gil Berglund ◽

Tomas Salmonson ◽

Jeanett Borregaard ◽

...

Keyword(s):

Breast Cancer ◽

Metastatic Breast Cancer ◽

Locally Advanced ◽

Metastatic Breast ◽

Medicinal Products ◽

Scientific Assessment ◽

The European Medicines Agency Review of Brentuximab Vedotin (Adcetris) for the Treatment of Adult Patients With Relapsed or Refractory CD30+ Hodgkin Lymphoma or Systemic Anaplastic Large Cell Lymphoma: Summary of the Scientific Assessment of the Committee for Medicinal Products for Human Use

The Oncologist ◽

10.1634/theoncologist.2015-0276 ◽

2015 ◽

Vol 21 (1) ◽

pp. 102-109 ◽

Cited By ~ 17

Author(s):

Iordanis Gravanis ◽

Kyriaki Tzogani ◽

Paula Hennik ◽

Pieter Graeff ◽

Petra Schmitt ◽

...

Keyword(s):

Hodgkin Lymphoma ◽

Anaplastic Large Cell Lymphoma ◽

Cell Lymphoma ◽

Large Cell ◽

Brentuximab Vedotin ◽

Medicinal Products ◽

Scientific Assessment ◽

Large Cell Lymphoma ◽